-
Mashup Score: 24Survival Outcomes of an Early Intervention Smoking Cessation Treatment After a Cancer Diagnosis - 6 hour(s) ago
This cohort study evaluates the survival outcomes of currently smoking patients with cancer who entered into a smoking cessation treatment program based on the time between diagnosis and program entry.
Source: jamanetwork.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 92
Adjuvant therapy with durvalumab, with or without tremelimumab, may have efficacy in patients with limited-stage small-cell lung cancer who do not have disease progression after standard concurrent…
Source: www.nejm.orgCategories: General Medicine News, Hem/OncsTweet-
🚨🔥 1/2 @OncoAlert Hot off the press. Just published @NEJM in conjunction with presentation on updated data @myESMO #ESMO2024 Results of #ADRIATIC trial of #Durvalumab vs #Placebo after #Chemoradiotherapy in Limited-Stage #SmallCell #LungCancer. 👇🏼 https://t.co/ElbWrwddii https://t.co/c6DTq1DORo
-
-
Mashup Score: 92
Adjuvant therapy with durvalumab, with or without tremelimumab, may have efficacy in patients with limited-stage small-cell lung cancer who do not have disease progression after standard concurrent…
Source: www.nejm.orgCategories: General Medicine News, Hem/OncsTweet-
🚨🔥 1/2 @OncoAlert Hot off the press. Just published @NEJM in conjunction with presentation on updated data @myESMO #ESMO2024 Results of #ADRIATIC trial of #Durvalumab vs #Placebo after #Chemoradiotherapy in Limited-Stage #SmallCell #LungCancer. 👇🏼 https://t.co/ElbWrwddii https://t.co/c6DTq1DORo
-
-
Mashup Score: 92
Adjuvant therapy with durvalumab, with or without tremelimumab, may have efficacy in patients with limited-stage small-cell lung cancer who do not have disease progression after standard concurrent…
Source: www.nejm.orgCategories: General Medicine News, Hem/OncsTweet-
🚨🔥 1/2 @OncoAlert Hot off the press. Just published @NEJM in conjunction with presentation on updated data @myESMO #ESMO2024 Results of #ADRIATIC trial of #Durvalumab vs #Placebo after #Chemoradiotherapy in Limited-Stage #SmallCell #LungCancer. 👇🏼 https://t.co/ElbWrwddii https://t.co/c6DTq1DORo
-
-
Mashup Score: 103
PURPOSEInternational medical graduates (IMGs) are an essential component of the oncology workforce in the United States, comprising a third of all practicing oncologists and almost half of hematology/oncology fellows. In this article, we discuss the …A guide to understanding and supporting international medical graduates in oncology by ASCO #IMG Community of Practice. Other suggested co-authors if there is space in the tweet: ASCO IMG Community of practice twitter handle @IMG_Oncologists @…
Source: ascopubs.orgCategories: General Medicine News, Hem/OncsTweet-
🔥🚨1/2 Hot off the press. Just published @JCOOP_ASCO #Guide to Understanding & Supporting #International #MedicalGraduates in #Hematology/#Oncology by @ASCO #IMGs Community of Practice. I’m honored to be part of this work with GREAT COLLEAGUES. 👇🏼 https://t.co/IdfytuTOWN https://t.co/tumkOhf3YG
-
-
Mashup Score: 74FDA approves osimertinib for non-small cell lung cancer - 2 month(s) ago
On September 25, 2024, the FDA approved osimertinib (Tagrisso, AstraZeneca Pharmaceuticals) for non-small cell lung cancer.
Source: www.fda.govCategories: General Medicine News, Hem/OncsTweet-
🔥🚨 @OncoAlert Hot off the press. As expected, @US_FDA approves #Osimertinib for #locallyadvanced #EGFR+ #NSCLC following concurrent or sequential #Chemoradiation. Approval based on #Laura trial: ⬆️#mPFS 39.1 (Osi) vs 5.6 months (placebo). HR 0.16 👇🏼 https://t.co/J1bZQmQPlO https://t.co/qNdBwrwSLx
-
-
Mashup Score: 74FDA approves osimertinib for non-small cell lung cancer - 2 month(s) ago
On September 25, 2024, the FDA approved osimertinib (Tagrisso, AstraZeneca Pharmaceuticals) for non-small cell lung cancer.
Source: www.fda.govCategories: General Medicine News, Hem/OncsTweet-
🔥🚨 @OncoAlert Hot off the press. As expected, @US_FDA approves #Osimertinib for #locallyadvanced #EGFR+ #NSCLC following concurrent or sequential #Chemoradiation. Approval based on #Laura trial: ⬆️#mPFS 39.1 (Osi) vs 5.6 months (placebo). HR 0.16 👇🏼 https://t.co/J1bZQmQPlO https://t.co/qNdBwrwSLx
-
-
Mashup Score: 26Blood and Marrow Transplant Fellowship (Florida) - Residencies and Fellowships - Mayo Clinic College of Medicine & Science - 2 month(s) ago
Mayo Clinic School of Graduate Medical Education offers a one-year Blood and Marrow Transplant Fellowship in Florida.
Source: college.mayo.eduCategories: General Medicine News, Hem/OncsTweet-
🚨📣To #HemOnc fellows, #ProgramDirectors & colleagues, our Florida @MayoClinic #Blood & #Marrow #Transplant (#BMT) #Fellowship program has an opening & accepting applications for 2025/2026. Plz share with those who may be interested. Program website👇🏼 https://t.co/dveaUqv45m https://t.co/hXMWI4PC0k
-
-
Mashup Score: 92
Adjuvant therapy with durvalumab, with or without tremelimumab, may have efficacy in patients with limited-stage small-cell lung cancer who do not have disease progression after standard concurrent…
Source: www.nejm.orgCategories: General Medicine News, Hem/OncsTweet-
🚨🔥 1/2 @OncoAlert Hot off the press. Just published @NEJM in conjunction with presentation on updated data @myESMO #ESMO2024 Results of #ADRIATIC trial of #Durvalumab vs #Placebo after #Chemoradiotherapy in Limited-Stage #SmallCell #LungCancer. 👇🏼 https://t.co/ElbWrwddii https://t.co/c6DTq1DORo
-
-
Mashup Score: 92
Adjuvant therapy with durvalumab, with or without tremelimumab, may have efficacy in patients with limited-stage small-cell lung cancer who do not have disease progression after standard concurrent…
Source: www.nejm.orgCategories: General Medicine News, Hem/OncsTweet-
🚨🔥 1/2 @OncoAlert Hot off the press. Just published @NEJM in conjunction with presentation on updated data @myESMO #ESMO2024 Results of #ADRIATIC trial of #Durvalumab vs #Placebo after #Chemoradiotherapy in Limited-Stage #SmallCell #LungCancer. 👇🏼 https://t.co/ElbWrwddii https://t.co/c6DTq1DORo
-
Not all #Patients with #Cancer have smoked but for those who have, #SmokingCessation improves ⬆️survival (& the earlier the better). 🔥🚨@OncoAlert Just published @JAMAOnc #Survival Outcomes of #Smoking #Cessation Treatment After Cancer Diagnosis. 👇🏼 https://t.co/1l4QwqQoWV https://t.co/jq4v327jvI